![](/img/cover-not-exists.png)
Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME ® trial
Fitchett, David, Zinman, Bernard, Wanner, Christoph, Lachin, John M., Hantel, Stefan, Salsali, Afshin, Johansen, Odd Erik, Woerle, Hans J., Broedl, Uli C., Inzucchi, Silvio E.Language:
english
Journal:
European Heart Journal
DOI:
10.1093/eurheartj/ehv728
Date:
January, 2016
File:
PDF, 465 KB
english, 2016